PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 8234758

New processing strategies for multichannel cochlear prostheses.

D T Lawson·B S Wilson·C C Finley
View original source ↗Export metadata ↓

Abstract

Various strategies for representing speech information with multichannel cochlear prostheses were compared in tests with implant patients. The strategies included the compressed analog (CA) approach of a standard clinical device, and alternative interleaved pulses (IP) and continuous interleaved sampling (CIS) strategies. CA and IP strategies had been compared in previous studies with a wide range of subjects. The present studies compared all three types in tests with one subject and CA and CIS strategies in tests with six additional subjects. Subjects for the present studies were selected for their excellent performance with the clinical CA processor, and the tests included closed-set identification of consonants and open-set recognition of words and sentences. For every test, every subject obtained his or her highest score, or repeated a score of 100% correct, using a CIS strategy. In the comparisons of all three approaches, IP processor scores were between those obtained with CA and CIS processors. The results are discussed in terms of their implications for processor design.

Explore related subjects

Cochlear ImplantsHearingHumansSignal Processing, Computer-AssistedSpeech PerceptionComparative StudyJournal ArticleResearch Support, U.S. Gov't, P.H.S.

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D T Lawson, B S Wilson, C C Finley. 1993. New processing strategies for multichannel cochlear prostheses.. https://doi.org/10.1016/s0079-6123(08)62291-8

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1999

Pseudospontaneous activity: stochastic independence of auditory nerve fibers with electrical stimulation.

We describe a novel signal processing strategy for cochlear implants designed to emphasize stochastic independence across the excited neural population. The strategy is based on the observation that high rate pulse trains may produce random spike patterns in auditory nerve fibers that are statistically similar to those produced by spontaneous activity in the normal cochlea. We call this activity 'pseudospontaneous'. A supercomputer-based computational model of a population of auditory nerve fibers suggests that different average rates of pseudospontaneous activity can be created by varying the stimulus current of a fixed-amplitude, high-rate pulse train, e.g. 5000 pps. Electrically-evoked compound action potentials recorded in a human cochlear implant subject are consistent with the hypothesis that such a stimulus can desynchronize the fiber population. This desynchronization may enhance neural representation of temporal detail and dynamic range with a cochlear implant and eliminate a major difference between acoustic and electric hearing.

Cochlear Implants↗
PubMed1999

The influence of ionizing radiation on the CLARION 1.2 cochlear implant during radiation therapy.

OBJECTIVE: This study aimed to determine the maximum dose of radiation the CLARION 1.2 cochlear implant can withstand safely. INTRODUCTION: Cochlear implants restore functional hearing to patients with sensorineural deafness. Because some patients may need radiation therapy, it is important to investigate the influence of ionizing radiation on cochlear implant function. METHODS: This study tested the function of four CLARION 1.2 implants (Advanced Bionics, Sylmar, CA, U.S.A.) after varying radiation treatments with gamma rays. The first implant received a cumulative dosage of 69 Gy over nine treatments (single doses between 0.1-30 Gy). The second was irradiated with a total of 90 Gy, receiving three treatments of 30 Gy each. The third and fourth received doses more typical of patient therapy (i.e., 2 Gy) approximately 30 times, for a cumulative dosage of approximately 60 Gy. Implant function was tested after every treatment; the CLARION implant incorporates a back-telemetry system, allowing impedance and current output testing. RESULTS: Despite the type of treatment, the results were quite consistent: difficulties in function occurred when the cumulative dosage inside the implant was approximately 60 Gy. The first implant recovered completely and the second recovered partially. DISCUSSION: The CLARION 1.2 cochlear implant seems to safely withstand approximately 60 Gy of radiation before experiencing functional difficulties. In a clinical situation, the implant would not likely be in the target volume irradiated, and thus the patient's therapeutic cumulative dosage might be higher.

Cochlear Implants↗